Clinuvel Pharmaceuticals Limited

ASX (AUD): Clinuvel Pharmaceuticals Limited (CUV)

Last Price

13.70

Today's Change

+0.12 (0.88%)

Day's Change

13.42 - 13.76

Trading Volume

54,819

Profile
CUV

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Philippe Jacques Wolgen M.B.A., M.D. Dr. Philippe Jacques Wolgen M.B.A., M.D.

Full Time Employees:  16 16

IPO Date:  2001-02-11 2001-02-11

CIK: 

ISIN:  AU000000CUV3 AU000000CUV3

CUSIP:  Q2516X144 Q2516X144

Beta:  0.85 0.85

Last Dividend:  0.05 0.05

Dcf Diff:  -7.15 -7.15

Dcf:  20.85 20.85

Description

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which provoke prolonged cellular activity; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. Clinuvel Pharmaceuticals Limited has a collaboration agreement with HK Winhealth Pharma Group Co. Limited t to treat EPP patients with SCENESSE under a named patient program in the People's Republic of China. The company was founded in 1987 and is headquartered in Melbourne, Australia.

Address

535 Bourke Street,
Melbourne, VIC 3000, AU

61 3 9660 4900

http://www.clinuvel.com

Discussions
Be the first to like this. Showing 2 of 2 comments

Heavenly PUNTER Lynas Boleh

Potential 20 baggers

2019-06-11 14:49

venom

wah sifu, you really know how to lepak around hor, kikikikikiki

2019-06-11 23:58

Post a Comment